Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Communicable and non-communicable co-morbidities and the presentation of COVID-19 in an African setting of high HIV-1 and tuberculosis prevalence

View ORCID ProfileElsa du Bruyn, Cari Stek, Remi Daroowala, Qonita Said-Hartley, Marvin Hsiao, View ORCID ProfileRene T. Goliath, Fatima Abrahams, Amanda Jackson, View ORCID ProfileSean Wasserman, View ORCID ProfileBrian W Allwood, View ORCID ProfileAngharad G. Davis, View ORCID ProfileRachel P-J. Lai, View ORCID ProfileAnna K. Coussens, View ORCID ProfileKatalin A. Wilkinson, View ORCID ProfileJantina de Vries, View ORCID ProfileNicki Tiffin, View ORCID ProfileMaddalena Cerrone, View ORCID ProfileNtobeko A. B. Ntusi, Catherine Riou, View ORCID ProfileRobert J. Wilkinson, Saalikha Aziz, Nonzwakazi Bangani, John Black, Marise Bremer, Wendy Burgers, Zandile Ciko, Hanif Esmail, Siamon Gordon, Yolande X. R. Harley, Francisco Lakay, Fernando-Oneissi Martinez-Estrada, Graeme Meintjes, Marc Mendelson, Tari Papavarnavas, Alize Proust, Sheena Ruzive, Georgia Schafer, Keboile Serole, Claire Whitaker, Kennedy Zvinairo on behalf of the HIATUS investigators
doi: https://doi.org/10.1101/2021.05.11.21256479
Elsa du Bruyn
1Wellcome Centre for Infectious Diseases Research in Africa
2Department of Medicine, University of Cape Town, Observatory 7925, Republic of South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Elsa du Bruyn
Cari Stek
3Department of Infectious Diseases, Imperial College London, W12 0NN, United Kingdom
1Wellcome Centre for Infectious Diseases Research in Africa
2Department of Medicine, University of Cape Town, Observatory 7925, Republic of South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Remi Daroowala
3Department of Infectious Diseases, Imperial College London, W12 0NN, United Kingdom
1Wellcome Centre for Infectious Diseases Research in Africa
2Department of Medicine, University of Cape Town, Observatory 7925, Republic of South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qonita Said-Hartley
4Department of Radiology, University of Cape Town, Observatory 7925, Republic of South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marvin Hsiao
5Department of Pathology, University of Cape Town, Observatory 7925, Republic of South Africa
6National Health Laboratory Service, Groote Schuur Complex, Department of Clinical Virology, Observatory 7925, Cape Town, Republic of South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rene T. Goliath
1Wellcome Centre for Infectious Diseases Research in Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rene T. Goliath
Fatima Abrahams
1Wellcome Centre for Infectious Diseases Research in Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amanda Jackson
1Wellcome Centre for Infectious Diseases Research in Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sean Wasserman
1Wellcome Centre for Infectious Diseases Research in Africa
2Department of Medicine, University of Cape Town, Observatory 7925, Republic of South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sean Wasserman
Brian W Allwood
7Division of Pulmonology, Department of Medicine, Stellenbosch University and Tygerberg Hospital, Cape Town, Republic of South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Brian W Allwood
Angharad G. Davis
1Wellcome Centre for Infectious Diseases Research in Africa
8The Francis Crick Institute, Midland Road, London, NW1 1AT, United Kingdom
9Division of Life Sciences, University College London, WC1E 6BT, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Angharad G. Davis
Rachel P-J. Lai
1Wellcome Centre for Infectious Diseases Research in Africa
3Department of Infectious Diseases, Imperial College London, W12 0NN, United Kingdom
8The Francis Crick Institute, Midland Road, London, NW1 1AT, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rachel P-J. Lai
Anna K. Coussens
1Wellcome Centre for Infectious Diseases Research in Africa
5Department of Pathology, University of Cape Town, Observatory 7925, Republic of South Africa
10The Walter and Eliza Hall Institute of Medical Research, Parkville Victoria 3052, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anna K. Coussens
Katalin A. Wilkinson
1Wellcome Centre for Infectious Diseases Research in Africa
2Department of Medicine, University of Cape Town, Observatory 7925, Republic of South Africa
8The Francis Crick Institute, Midland Road, London, NW1 1AT, United Kingdom
9Division of Life Sciences, University College London, WC1E 6BT, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Katalin A. Wilkinson
Jantina de Vries
2Department of Medicine, University of Cape Town, Observatory 7925, Republic of South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jantina de Vries
Nicki Tiffin
1Wellcome Centre for Infectious Diseases Research in Africa
11Health Impact Assessment unit, Western Cape Department of Health, Cape Town, Republic of South Africa
12Centre for Infectious Disease Epidemiology and Research, School of Public Health and Family Medicine, University of Cape Town, Observatory 7925, Republic of South Africa
13Division of Computational Biology, University of Cape Town, Observatory 7925, Republic of South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nicki Tiffin
Maddalena Cerrone
1Wellcome Centre for Infectious Diseases Research in Africa
3Department of Infectious Diseases, Imperial College London, W12 0NN, United Kingdom
8The Francis Crick Institute, Midland Road, London, NW1 1AT, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Maddalena Cerrone
Ntobeko A. B. Ntusi
1Wellcome Centre for Infectious Diseases Research in Africa
2Department of Medicine, University of Cape Town, Observatory 7925, Republic of South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ntobeko A. B. Ntusi
Catherine Riou
1Wellcome Centre for Infectious Diseases Research in Africa
5Department of Pathology, University of Cape Town, Observatory 7925, Republic of South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Robert.Wilkinson{at}uct.ac.za cr.riou{at}uct.ac.za
Robert J. Wilkinson
1Wellcome Centre for Infectious Diseases Research in Africa
2Department of Medicine, University of Cape Town, Observatory 7925, Republic of South Africa
3Department of Infectious Diseases, Imperial College London, W12 0NN, United Kingdom
8The Francis Crick Institute, Midland Road, London, NW1 1AT, United Kingdom
9Division of Life Sciences, University College London, WC1E 6BT, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Robert J. Wilkinson
  • For correspondence: Robert.Wilkinson{at}uct.ac.za cr.riou{at}uct.ac.za
14See supplemental data for complete list of investigators
Saalikha Aziz
1Wellcome Centre for Infectious Diseases Research in Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nonzwakazi Bangani
1Wellcome Centre for Infectious Diseases Research in Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Black
15Livingstone Hospital, Port Elizabeth 6020, Republic of South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marise Bremer
1Wellcome Centre for Infectious Diseases Research in Africa
15Livingstone Hospital, Port Elizabeth 6020, Republic of South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wendy Burgers
1Wellcome Centre for Infectious Diseases Research in Africa
5Department of Pathology, University of Cape Town, Observatory 7925, Republic of South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zandile Ciko
1Wellcome Centre for Infectious Diseases Research in Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hanif Esmail
16MRC Clinical Trials Unit, University College London, WC1V 6LJ, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Siamon Gordon
17Sir William Dunn School of Pathology, University of Oxford, OX1 3RE, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yolande X. R. Harley
1Wellcome Centre for Infectious Diseases Research in Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francisco Lakay
1Wellcome Centre for Infectious Diseases Research in Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fernando-Oneissi Martinez-Estrada
18University of Surrey, Guildford GU2 7XH, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Graeme Meintjes
1Wellcome Centre for Infectious Diseases Research in Africa
2Department of Medicine, University of Cape Town, Observatory 7925, Republic of South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc Mendelson
1Wellcome Centre for Infectious Diseases Research in Africa
2Department of Medicine, University of Cape Town, Observatory 7925, Republic of South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tari Papavarnavas
2Department of Medicine, University of Cape Town, Observatory 7925, Republic of South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alize Proust
8The Francis Crick Institute, Midland Road, London, NW1 1AT, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sheena Ruzive
1Wellcome Centre for Infectious Diseases Research in Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Georgia Schafer
1Wellcome Centre for Infectious Diseases Research in Africa
19International Centre for Genetic Engineering and Biotechnology, University of Cape Town Campus, Observatory 7925, Republic of South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Keboile Serole
1Wellcome Centre for Infectious Diseases Research in Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claire Whitaker
1Wellcome Centre for Infectious Diseases Research in Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kennedy Zvinairo
1Wellcome Centre for Infectious Diseases Research in Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Objectives To describe the presentation and outcome of SARS-CoV2 infection in an African setting of high non-communicable co-morbidity and also HIV-1 and tuberculosis prevalence.

Design Case control analysis with cases stratified by HIV-1 and tuberculosis status.

Setting A single-centre observational case-control study of adults admitted to a South African hospital with proven SARS-CoV-2 infection or alternative diagnosis.

Participants 104 adults with RT-PCR-proven SARS-CoV2 infection of which 55 (52.9%) were male and 31 (29.8%) HIV-1 co-infected. 40 adults (35.7% male, 30.9% HIV-1 co-infected) admitted during the same period with no RT-PCR or serological evidence of SARS-CoV2 infection and assigned alternative diagnoses. Additional in vitro data from prior studies of 72 healthy controls and 118 HIV-1 uninfected and infected persons participants enrolled to a prior study with either immune evidence of tuberculosis sensitization but no symptoms or microbiologically confirmed pulmonary tuberculosis.

Results Two or more co-morbidities were present in 57.7% of 104 RT-PCR proven COVID-19 presentations, the commonest being hypertension (48%), type 2 diabetes mellitus (39%), obesity (31%) but also HIV-1 (30%) and active tuberculosis (14%). Amongst patients dually infected by tuberculosis and SARS-CoV-2, clinical features could be dominated by either SARS-CoV-2 or tuberculosis: lymphopenia was exacerbated, and some markers of inflammation (D-dimer and ferritin) elevated in singly SARS-CoV-2 infected patients were even further elevated (p < 0.05). HIV-1 and SARS-CoV2 co-infection resulted in lower absolute number and proportion of CD4 lymphocytes, with those in the lowest peripheral CD4 percentage strata exhibiting absent or lower antibody responses against SARS-CoV2. Death occurred in 30/104 (29%) of all COVID-19 patients and in 6/15 (40%) of patients with coincident SARS-CoV-2 and tuberculosis.

Conclusions In this South African setting, HIV-1 and tuberculosis are common co-morbidities in patients presenting with COVID-19. In environments in which tuberculosis is common, SARS-CoV-2 and tuberculosis may co-exist with clinical presentation being typical of either disease. Clinical suspicion of exacerbation of co-existent tuberculosis accompanying SARS-CoV-2 should be high.

What is already known on this topic?It has been quite widely thought that Africa has been spared the worst effects of the COVID-19 pandemic. There are very few reported case series and no case-control studies comparing COVID-19 patients admitted to hospital to those admitted for other reasons. However several studies have indicated both HIV-1 and tuberculosis co-infection that are endemic in Africa constitute risk factors for poor outcome. In addition Africa is subject to demographic transition and the prevalence of non-communicable co-morbidities such as type 2 diabetes, hypertension and cardiovascular disease is rising rapidly. No study from Africa has described the clinical impact on the presentation of COVID-19 infection.

What this study adds Two or more co-morbidities were present in over half COVID-19 presentations, including HIV-1 (30%) and active tuberculosis (14%). Patients dually infected by tuberculosis and SARS-CoV-2, presented as either SARS-CoV-2 or tuberculosis. HIV-1 and SARS-CoV2 co-infection resulted in lower absolute number and proportion of CD4 lymphocytes, and those with low CD4 counts had absent or lower antibody responses against SARS-CoV2. Death occurred 29% of all COVID-19 patients and in 40% of patients with coincident SARS-CoV-2 and tuberculosis. Thus in environments in which tuberculosis is common, SARS-CoV-2 and tuberculosis may co-exist with clinical presentation being typical of either disease and clinical suspicion of exacerbation of co-existent tuberculosis accompanying SARS-CoV-2 should be high.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This research was funded in whole, or in part, by Wellcome [104803, 203135, 222754]. For the purpose of Open Access, the author has applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission. RJW was supported by the Francis Crick Institute which receives its core funding from Cancer Research UK (FC0010218), the UK Medical Research Council (FC0010218), and Wellcome (FC0010218).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was approved by the University of Cape Town Health Sciences Research Ethical Committee (HREC 207/2020)

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data will be made available following formal publication via contact with the corresponding author

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted May 11, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Communicable and non-communicable co-morbidities and the presentation of COVID-19 in an African setting of high HIV-1 and tuberculosis prevalence
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Communicable and non-communicable co-morbidities and the presentation of COVID-19 in an African setting of high HIV-1 and tuberculosis prevalence
Elsa du Bruyn, Cari Stek, Remi Daroowala, Qonita Said-Hartley, Marvin Hsiao, Rene T. Goliath, Fatima Abrahams, Amanda Jackson, Sean Wasserman, Brian W Allwood, Angharad G. Davis, Rachel P-J. Lai, Anna K. Coussens, Katalin A. Wilkinson, Jantina de Vries, Nicki Tiffin, Maddalena Cerrone, Ntobeko A. B. Ntusi, Catherine Riou, Robert J. Wilkinson, Saalikha Aziz, Nonzwakazi Bangani, John Black, Marise Bremer, Wendy Burgers, Zandile Ciko, Hanif Esmail, Siamon Gordon, Yolande X. R. Harley, Francisco Lakay, Fernando-Oneissi Martinez-Estrada, Graeme Meintjes, Marc Mendelson, Tari Papavarnavas, Alize Proust, Sheena Ruzive, Georgia Schafer, Keboile Serole, Claire Whitaker, Kennedy Zvinairo
medRxiv 2021.05.11.21256479; doi: https://doi.org/10.1101/2021.05.11.21256479
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Communicable and non-communicable co-morbidities and the presentation of COVID-19 in an African setting of high HIV-1 and tuberculosis prevalence
Elsa du Bruyn, Cari Stek, Remi Daroowala, Qonita Said-Hartley, Marvin Hsiao, Rene T. Goliath, Fatima Abrahams, Amanda Jackson, Sean Wasserman, Brian W Allwood, Angharad G. Davis, Rachel P-J. Lai, Anna K. Coussens, Katalin A. Wilkinson, Jantina de Vries, Nicki Tiffin, Maddalena Cerrone, Ntobeko A. B. Ntusi, Catherine Riou, Robert J. Wilkinson, Saalikha Aziz, Nonzwakazi Bangani, John Black, Marise Bremer, Wendy Burgers, Zandile Ciko, Hanif Esmail, Siamon Gordon, Yolande X. R. Harley, Francisco Lakay, Fernando-Oneissi Martinez-Estrada, Graeme Meintjes, Marc Mendelson, Tari Papavarnavas, Alize Proust, Sheena Ruzive, Georgia Schafer, Keboile Serole, Claire Whitaker, Kennedy Zvinairo
medRxiv 2021.05.11.21256479; doi: https://doi.org/10.1101/2021.05.11.21256479

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Respiratory Medicine
Subject Areas
All Articles
  • Addiction Medicine (430)
  • Allergy and Immunology (756)
  • Anesthesia (221)
  • Cardiovascular Medicine (3292)
  • Dentistry and Oral Medicine (364)
  • Dermatology (279)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1171)
  • Epidemiology (13374)
  • Forensic Medicine (19)
  • Gastroenterology (899)
  • Genetic and Genomic Medicine (5153)
  • Geriatric Medicine (482)
  • Health Economics (783)
  • Health Informatics (3268)
  • Health Policy (1140)
  • Health Systems and Quality Improvement (1190)
  • Hematology (431)
  • HIV/AIDS (1017)
  • Infectious Diseases (except HIV/AIDS) (14627)
  • Intensive Care and Critical Care Medicine (913)
  • Medical Education (477)
  • Medical Ethics (127)
  • Nephrology (523)
  • Neurology (4925)
  • Nursing (262)
  • Nutrition (730)
  • Obstetrics and Gynecology (883)
  • Occupational and Environmental Health (795)
  • Oncology (2524)
  • Ophthalmology (724)
  • Orthopedics (281)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (543)
  • Pediatrics (1302)
  • Pharmacology and Therapeutics (550)
  • Primary Care Research (557)
  • Psychiatry and Clinical Psychology (4212)
  • Public and Global Health (7504)
  • Radiology and Imaging (1705)
  • Rehabilitation Medicine and Physical Therapy (1013)
  • Respiratory Medicine (980)
  • Rheumatology (480)
  • Sexual and Reproductive Health (497)
  • Sports Medicine (424)
  • Surgery (548)
  • Toxicology (72)
  • Transplantation (236)
  • Urology (205)